Related Experiment Video
Updated: Aug 9, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Neuropharmacological Aspects of ECT: In Search of the Primary Mechanism of Action
David J. Nutt1, Christoph H. Gleiter, Paul Glue
1Reckitt and Colman Psychopharmacology Unit, Medical School, Bristol, UK.
Abstract:
Since its first use in humans 50 years ago, electroconvulsive therapy has been a controversial topic. Nevertheless, a great many experimental and clinical data have been collected. Much of it strengthens the notion that ECT is a more specific therapy than it appears at first sight. The pharmacological effects of ECT seem to be directed toward changes in signal transduction chain processes in the synapse and on the postsynaptic cell membrane. Some aspects of this have been well investigated, especially the effects of ECT on membrane receptors, whereas others have only recently evolved. This article discusses some general principles and conclusions and focuses on some very recent data acquired with new laboratory techniques, such as in vivo dialysis and molecular biology. An attempt is made to interpret these new data and to integrate them in previous results.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
07:47A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver
Published on: May 19, 2026
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Antiepileptic Drugs: Glutamate Antagonists
Electroconvulsive Therapy